FDA Issues Revised Draft Guidance on "Off-Label" Communicati

The FDA issued Revised Draft Guidance addressing communications by drug and device manufacturers about “off-label” uses of approved products. The Revised Draft Guidance...

Related Keywords

, Categories Of Communications , Communications Should Not Use Persuasive Marketing Techniques , Device Manufacturer Communications With Payors , Drug Administration , Communications Should Be Clinically Relevant , Revised Draft Guidance , Medical Publications , Unapproved New Uses , From Firms , Unapproved Uses , Cleared Medical Products , Recommended Practices , Federal Food , Cosmetic Act , Draft Guidance , Differences Between , Should Not Use , World Data , First Amendment , Use Final Rule , Formulary Committees , Similar Entities ,